Literature DB >> 35497669

Celiac Disease Revisited.

João Calado1, Mariana Verdelho Machado1,2.   

Abstract

Celiac disease (CD) is a systemic disease triggered by gluten ingestion in genetically predisposed individuals. It manifests primarily as an autoimmune enteropathy associated with specific circulating autoantibodies and a human leukocyte antigen haplotype (HLA-DQ2 or HLA-DQ8). It afflicts roughly 1% of the population, though the majority of patients remain undiagnosed. Diarrhea and malabsorption are classic manifestations of CD; however, both children and adults can be paucisymptomatic and present extraintestinal manifestations such as anemia, osteoporosis, and abnormal liver tests. CD screening is not recommended for the general population, and it should be focused on high-risk groups. CD diagnosis is challenging and relies on serological tests, duodenal histology, and genetic testing. Particularly difficult presentations to manage are seronegative patients, seropositive patients without villus atrophy, and patients who have started a gluten-free diet before the diagnostic workup. The only proven treatment is a lifelong gluten-free diet. We present an in-depth review on the physiopathology and management of CD, with a particular emphasis on diagnostic challenges.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Celiac disease; Diagnostic challenges; Duodenal histology; Human leukocyte antigen; Serological tests

Year:  2021        PMID: 35497669      PMCID: PMC8995660          DOI: 10.1159/000514716

Source DB:  PubMed          Journal:  GE Port J Gastroenterol        ISSN: 2387-1954


  166 in total

Review 1.  Overview and pathogenesis of celiac disease.

Authors:  Martin F Kagnoff
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

Review 2.  Dendritic cells in intestinal homeostasis and disease.

Authors:  Maria Rescigno; Antonio Di Sabatino
Journal:  J Clin Invest       Date:  2009-09-01       Impact factor: 14.808

3.  A major role for matrix metalloproteinases in T cell injury in the gut.

Authors:  S L Pender; S P Tickle; A J Docherty; D Howie; N C Wathen; T T MacDonald
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

4.  Lymphoma development and survival in refractory coeliac disease type II: Histological response as prognostic factor.

Authors:  P Nijeboer; Rlj van Wanrooij; T van Gils; N J Wierdsma; G J Tack; B I Witte; H J Bontkes; O Visser; Cjj Mulder; G Bouma
Journal:  United European Gastroenterol J       Date:  2016-06-23       Impact factor: 4.623

5.  Coeliac disease: clinical features in adult populations.

Authors:  A Fernández; L González; J de-la-Fuente
Journal:  Rev Esp Enferm Dig       Date:  2010-07       Impact factor: 2.086

Review 6.  Epidemiology of Celiac Disease.

Authors:  Jonas F Ludvigsson; Joseph A Murray
Journal:  Gastroenterol Clin North Am       Date:  2018-12-13       Impact factor: 3.806

7.  Seronegative celiac disease: Shedding light on an obscure clinical entity.

Authors:  Umberto Volta; Giacomo Caio; Elisa Boschetti; Fiorella Giancola; Kerry J Rhoden; Eugenio Ruggeri; Paola Paterini; Roberto De Giorgio
Journal:  Dig Liver Dis       Date:  2016-06-11       Impact factor: 4.088

Review 8.  Association of celiac disease and intestinal lymphomas and other cancers.

Authors:  Carlo Catassi; Italo Bearzi; Geoffrey K T Holmes
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

9.  European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders.

Authors:  Abdulbaqi Al-Toma; Umberto Volta; Renata Auricchio; Gemma Castillejo; David S Sanders; Christophe Cellier; Chris J Mulder; Knut E A Lundin
Journal:  United European Gastroenterol J       Date:  2019-04-13       Impact factor: 4.623

Review 10.  Coeliac disease.

Authors:  Benjamin Lebwohl; David S Sanders; Peter H R Green
Journal:  Lancet       Date:  2017-07-28       Impact factor: 79.321

View more
  1 in total

Review 1.  Celiac Disease and Targeting the Molecular Mechanisms of Autoimmunity in COVID Pandemic.

Authors:  Laura Marinela Ailioaie; Constantin Ailioaie; Gerhard Litscher; Dragos Andrei Chiran
Journal:  Int J Mol Sci       Date:  2022-07-13       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.